All Stories

  1. Association Between Hemoglobin Levels, Anemia, and Blood Pressure in Hypertensive Adults: A Retrospective Study

    Article • Biomedical & Pharmacology Journal, December 2025, Oriental Scientific Publishing Company

    Professor Mahir Khalil Ibrahim Jallo

  2. Use of Fixed Ratio Combinations to Improve Glycemic Control in Individuals with Type 2 Diabetes: Experts’ Opinion from the Gulf Region

    Article • Diabetes Therapy, December 2025, Springer Science + Business Media

    Professor Mahir Khalil Ibrahim Jallo

  3. Role of Adiponectin in Modulating Insulin Resistance in Visceral Obesity-Associated Type 2 Diabetes Mellitus

    Article • Journal of Endocrinology and Metabolism, October 2025, Elmer Press, Inc.

    Professor Mahir Khalil Ibrahim Jallo

  4. Effect of Semaglutide Add-on to Metformin on Visceral Adiposity Index and Markers of Visceral Adipose Tissue Activity in Type 2 Diabetic Patients

    Article • Biomedical & Pharmacology Journal, June 2025, Oriental Scientific Publishing Company

    Professor Mahir Khalil Ibrahim Jallo

  5. Prevalence of cardiovascular risk and atherosclerotic cardiovascular disease in people with type 2 diabetes in the United Arab Emirates: Results from the prevalence of atherosclerotic cardiovascular disease in patients with type 2 diabetes across Middl...

    Article • Diabetes & Metabolic Syndrome Clinical Research & Reviews, April 2025, Elsevier

    Professor Mahir Khalil Ibrahim Jallo

  6. The Medication-Related Burden Quality of Life (MRB-QoL) tool: A confirmatory factor analysis of the Arabic version

    Article • Exploratory Research in Clinical and Social Pharmacy, March 2025, Elsevier

    Professor Mahir Khalil Ibrahim Jallo

  7. O-SEMA-FAST: A Prospective, Non-interventional Study Investigating Oral Semaglutide Use in Adults with Type 2 Diabetes Mellitus During Ramadan

    Article • Diabetes Therapy, February 2025, Springer Science + Business Media

    Professor Mahir Khalil Ibrahim Jallo

  8. Artificial intelligence for the detection of acute myeloid leukemia from microscopic blood images; a systematic review and meta-analysis

    Article • Frontiers in Big Data, January 2025, Frontiers

    Professor Mahir Khalil Ibrahim Jallo

  9. Current Perspectives in Pre- and Diabetic Peripheral Neuropathy Diagnosis and Management: An Expert Statement for the Gulf Region

    Article • Diabetes Therapy, October 2024, Springer Science + Business Media

    Professor Mahir Khalil Ibrahim Jallo

  10. Visceral Fat-associated Adipokines and Metabolic Variables in Central Obese Type 2 Diabetic Patients

    Article • New Emirates Medical Journal, May 2024, Bentham Science Publishers

    Professor Mahir Khalil Ibrahim Jallo, Palat Krishna Menon

  11. Patient and Healthcare Professional Satisfaction with the OneTouch Verio Reflect® Blood Glucose Monitoring System in the UAE

    Article • Current Diabetes Reviews, June 2023, Bentham Science Publishers

    Asif Khan , Professor Mahir Khalil Ibrahim Jallo, Mike Grady

  12. Switching to a fixed-ratio combination of insulin degludec/liraglutide (IDegLira) is associated with improved glycaemic control in a real-world population with type 2 diabetes mellitus in the United Arab Emirates: Results from the multicentre, prospect...

    Article • Diabetes Research and Clinical Practice, February 2023, Elsevier

    Professor Mahir Khalil Ibrahim Jallo

  13. Abstract #1313460: Intestinal Flora and Gestational Diabetes: Where We Are in 2022?

    Article • Endocrine Practice, December 2022, Elsevier

    Professor Mahir Khalil Ibrahim Jallo

  14. Abstract #1313472: Adherence of Physicians to Evidence-Based Management Guidelines for Treating Type 2 Diabetes and Atherosclerotic Cardiovascular Disease in Ajman, United Arab Emirates

    Article • Endocrine Practice, December 2022, Elsevier

    Professor Mahir Khalil Ibrahim Jallo

  15. Depression among Adult Diabetics in the UAE

    Article • International Journal of Pharmaceutical Quality Assurance, September 2022, Dr. Yashwant Research Labs Pvt. Ltd.

    Professor Mahir Khalil Ibrahim Jallo

  16. Effect of Add-On Therapy of Sodium-Glucose Cotransporter 2 Inhibitors and Dipeptidyl Peptidase 4 Inhibitors on Adipokines in Type 2 Diabetes Mellitus

    Article • Diabetologie und Stoffwechsel, May 2022, Thieme Publishing Group

    Professor Mahir Khalil Ibrahim Jallo

  17. Adherence of physicians to evidence-based management guidelines for treating type 2 diabetes and atherosclerotic cardiovascular disease in Ajman, United Arab Emirates

    Article • BMC Primary Care, April 2022, Springer Science + Business Media

    Professor Mahir Khalil Ibrahim Jallo

  18. Ameliorating effect of erythropoietin in a severe case of COVID-19: case report

    Article • Pan African Medical Journal, January 2022, Pan African Medical Journal

    Professor Mahir Khalil Ibrahim Jallo

  19. Effect of Add-On Therapy of Dapagliflozin and Empagliflozin on Adipokines in Type 2 Diabetes Mellitus

    Article • Journal of Endocrinology and Metabolism, August 2021, Elmer Press, Inc.

    Professor Mahir Khalil Ibrahim Jallo

  20. Effect of Add-On Therapy of Sodium-Glucose Cotransporter 2 Inhibitors and Dipeptidyl Peptidase 4 Inhibitors on Adipokines in Type 2 Diabetes Mellitus

    Article • Journal of Clinical Medicine Research, June 2021, Elmer Press, Inc.

    Professor Mahir Khalil Ibrahim Jallo

  21. Prevalence of Cardiovascular and Renal Co-morbidities in Patients with Type 2 Diabetes in the Gulf, a Cross-sectional Observational Study

    Article • Diabetes Therapy, March 2021, Springer Science + Business Media

    Professor Mahir Khalil Ibrahim Jallo

  22. Hypoglycaemia Among Insulin-Treated Patients with Diabetes: Evaluation of the United Arab Emirates cohort of the International Operations-Hypoglycaemia Assessment Tool study

    Article • Sultan Qaboos University Medical Journal, March 2019, Sultan Qaboos University Medical Journal

    Professor Mahir Khalil Ibrahim Jallo

  23. Effectiveness and tolerability of second-line treatment with vildagliptin versus other oral drugs for type 2 diabetes in a real-world setting in the Middle East: results from the EDGE study

    Article • Vascular Health and Risk Management, February 2015, Taylor & Francis

    giovanni bader, Professor Mahir Khalil Ibrahim Jallo

  24. Effectiveness and tolerability of second‐line therapy with vildagliptin vs. other oral agents in type 2 diabetes: A real‐life worldwide observational study (EDGE)

    Article • International Journal of Clinical Practice, August 2013, Hindawi Publishing Corporation

    Professor Mahir Khalil Ibrahim Jallo

  25. Diabetes and depression: The impact of fluoxetine on glycemic control

    Article • European Psychiatry, March 2007, Cambridge University Press

    Professor Mahir Khalil Ibrahim Jallo